The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin
Abstract
EGFR is a potent stimulator of invasion and metastasis in head and neck squamous cell carcinomas (HNSCC). However, the mechanism by which EGFR may stimulate tumor cell invasion and metastasis still need to be elucidated. In this study, we showed that activation of EGFR by EGF in HNSCC cell line SCC10A enhanced cell migration and invasion, and induced loss of epitheloid phenotype in parallel with downregulation of E‐cadherin and upregulation of N‐cadherin and vimentin, indicating that EGFR promoted SCC10A cell migration and invasion possibly by an epithelial to mesenchymal transition (EMT)‐like phenotype change. Interestingly, activation of EGFR by EGF induced production of matrix metalloproteinase‐9 (MMP‐9) and soluble E‐cadherin (sE‐cad), and knockdown of MMP‐9 by siRNA inhibited sE‐cad production induced by EGF in SCC10A. Moreover, both MMP‐9 knockdown and E‐cadherin overexpression inhibited cell migration and invasion induced by EGF in SCC10A. The results indicate that EGFR activation promoted cell migration and invasion through inducing MMP‐9‐mediated degradation of E‐cadherin into sE‐cad. Pharmacologic inhibition of EGFR, MEK, and PI3K kinase activity in SCC10A reduced phosphorylated levels of ERK‐1/2 and AKT, production of MMP‐9 and sE‐cad, cell migration and invasion, and expressional changes of EMT markers (E‐cadherin and N‐cadherin) induced by EGF, indicating that EGFR activation promotes cell migration and invasion via ERK‐1/2 and PI3K‐regulated MMP‐9/E‐cadherin signaling pathways. Taken together, the data suggest that EGFR activation promotes HNSCC SCC10A cell migration and invasion by inducing EMT‐like phenotype change and MMP‐9‐mediated degradation of E‐cadherin into sE‐cad related to activation of ERK‐1/2 and PI3K signaling pathways. J. Cell. Biochem. 112: 2508–2517, 2011. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
The cell-cell adhesion molecule E-cadherin
van Roy, F., & Berx, G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8281-1 · Cited by 1,325
Extracellular matrix remodelling: the role of matrix metalloproteinases
Stamenkovic, I. (2003) · The Journal of Pathology · doi:10.1002/path.1400 · Cited by 1,140
Matrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 765
Epidermal Growth Factor Receptor Biology in Head and Neck Cancer
Kalyankrishna, S., & Grandis, J. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.8306 · Cited by 747
Matrix metalloproteinases (MMPs) in health and disease: an overview
Malemud, C. (2006) · Frontiers in Bioscience · doi:10.2741/1915 · Cited by 705
Mutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Köhrmann, A., Kammerer, U., Kapp, M., Dietl, J., & Anacker, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-188 · Cited by 384
Chinni, S. R., Sivalogan, S., Dong, Z., Filho, J. C. T., Deng, X., Bonfil, R. D., & Cher, M. L. (2006) · The Prostate · doi:10.1002/pros.20318 · Cited by 245
Hulit, J., Suyama, K., Chung, S., Keren, R., Agiostratidou, G., Shan, W., Dong, X., Williams, T. M., Lisanti, M. P., Knudsen, K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3401 · Cited by 218
Matrix metalloproteases in head and neck cancer
Rosenthal, E. L., & Matrisian, L. M. (2006) · Head & Neck · doi:10.1002/hed.20365 · Cited by 208
TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma
Kupferman, M. E., Jiffar, T., El-Naggar, A., Yilmaz, T., Zhou, G., Xie, T., Feng, L., Wang, J., Holsinger, F. C., Yu, D., et al. (2010) · Oncogene · doi:10.1038/onc.2009.486 · Cited by 200
O‐charoenrat, P., Modjtahedi, H., Rhys‐Evans, P., Court, W. J., Box, G., & Eccles, S. A. (2000) · PubMed · Cited by 159
Thant, A. A., Nawa, A., Kikkawa, F., Ichigotani, Y., Zhang, Y., Sein, T. T., Amin, A. R. M. R., & Hamaguchi, M. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1010921730952 · Cited by 146
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review)
Libra, M. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000215 · Cited by 134
Chen, L. F., Cohen, E. E. W., & Grandis, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2318 · Cited by 120
Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract
Natalwala, A., Spychal, R., & Tselepis, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3792 · Cited by 119
Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck
Reuter, C. W., Morgan, M. A., & Eckardt, A. M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603566 · Cited by 113
Thomas, S. M., Coppelli, F. M., Wells, A. H., Gooding, W. E., Song, J. I., Kassis, J. N., Drenning, S. D., & Grandis, J. R. (2003) · PubMed · Cited by 110
Integrin Engagement Differentially Modulates Epithelial Cell Motility by RhoA/ROCK and PAK1
Zhou, H., & Kramer, R. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411900200 · Cited by 109
Emerging drugs to treat squamous cell carcinomas of the head and neck
Fung, C., & Grandis, J. R. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.497754 · Cited by 108
Ali, M. A. L. S., Gündüz, M., Nagatsuka, H., Gündüz, E., Cengiz, B., Fukushima, K., BEDER, L. B., Demircan, K., Fujii, M., Yamanaka, N., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00861.x · Cited by 104
Amin, A. R. M. R., Senga, T., Oo, M. L., Thant, A. A., & Hamaguchi, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00652.x · Cited by 95
Timpson, P., Wilson, A. S., Lehrbach, G. M., Sutherland, R. L., Musgrove, E. A., & Daly, R. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0798 · Cited by 94
Molecular therapy in head and neck oncology
Bernier, J., Bentzen, S. M., & Vermorken, J. B. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.40 · Cited by 93
Egloff, A. M., Rothstein, M. E., Seethala, R. R., Siegfried, J. M., Grandis, J. R., & Stabile, L. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0862 · Cited by 89
Zuo, J., Ishikawa, T., Boutros, S., Xiao, Z., Humtsoe, J. O., & Kramer, R. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0354 · Cited by 76
Self-citationSchaaij‐Visser, T. B. M., Graveland, A. P., Gauci, S., Braakhuis, B. J. M., Buijze, M., Heck, A. J. R., Kuik, D. J., Bloemena, E., Leemans, C. R., Slijper, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2134 · Cited by 75
Hoffmann, T. K., Häfner, D., Balló, H., et al. (1998) · PubMed · Cited by 68
Sen, T., Dutta, A., Maity, G., & Chatterjee, A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.07.005 · Cited by 60
Lungu, G. F., Covaleda, L. M., Mendes, O. R., et al. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20398 · Cited by 53
Lin, M., Chang, C.-C., Lin, B., Yang, H., Chu, C., Wu, M., & Kuo, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706600200 · Cited by 52
Molecular targeted therapy of head and neck cancer: Review and clinical development challenges
Tourneau, C. L., Faivre, S. J., & Siu, L. L. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.016 · Cited by 43
Grandis, J. R., Pietenpol, J. A., Greenberger, J. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2445 · Cited by 35
Mantha, A. J., McFee, K. E., Niknejad, N., Goss, G. D., Lorimer, I. A. J., & Dimitroulakos, J. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0490-2 · Cited by 34
Valkova, C., Mertens, C., Weisheit, S., Imhof, D., & Liebmann, C. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0164 · Cited by 10
Cited by
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Xu, W., Yang, Z., & Lu, N. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1016686 · Cited by 608
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC
Joseph, J. P., Harishankar, M. K., Pillai, A. A., & Devi, A. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.03.004 · Cited by 282
Nuclear signaling from cadherin adhesion complexes
McCrea, P. D., Maher, M. T., & Gottardi, C. J. (2015) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2014.11.018 · Cited by 85
Byeon, H. K., Na, H. J., Yang, Y. J., Ko, S., Yoon, S. O., Ku, M., Yang, J., Kim, J. W., Ban, M. J., Kim, J.-H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.13480 · Cited by 29
Wang, X., Li, X., & Wang, Z. (2021) · Oncology Reports · doi:10.3892/or.2021.7991 · Cited by 24
Self-citation
Metadata
- Authors
- Zuo, J., Zhu, W., Li, M., Li, X., Yi, H., Zeng, G., Wan, X., He, Q., Li, J., Qu, J., Chen, Y., & Xiao, Z.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2011-08-18
- Volume
- 112
- Issue
- 9
- Pages
- 2508-2517
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1972316552
- Cited by
- 258
- References
- 40
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.